News | March 26, 2014

Improved Magnesium Diboride Wires Deliver MRI-Level Image Quality

MRI scans, magnesium diboride
March 26, 2014 -- Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership. CES, Inc. developed a proprietary technology based on magnesium diboride superconducting wire, which enabled cryogen-free 1.5T and 3.0T magnetic resonance imaging (MRI) with image qualities similar to the currently available 1.5T MRI. The technology leveraged innovative customizations in the chemistry of the material by adding both magnetic and non-magnetic impurities to magnesium diboride wires. This resulted in improvements to the critical currents of superconducting magnesium diboride wires.
 
The cryogen-free 0.5T MRI delivers images of average quality when compared to 1.5T MRI, as the quality of image is directly dependent on the square of the strength of the magnetic field. However, the current 1.5T MRI technology requires the use of cost-intensive liquid helium, which increases the cost of maintenance and operation, as well as initial cost.
 
"The next-generation, cryogen-free 1.5T and 3.0T MRI technology promises a reduction in the MRI scan cost by up to 40 percent due to the financial viability and simplicity of the MRI equipment," said Frost & Sullivan Senior Research Analyst Avimanu Basu. "This cost-effectiveness is achieved by maintaining a higher operating temperature of 20 degrees K with the help of a cryocooler, which eliminates the need for expensive liquid helium."
 
Furthermore, the technology is maintenance-free and extends the equipment's longevity to 10 to 20 years. The presently available MRI has a lifetime of five to seven years and is complex and expensive to maintain, as it employs superconducting NbTi wires that operate at a temperature of 4 degrees K. This necessitates cooling with the help of 1,700 liters of liquid helium cryogen.
 
"CES, Inc.'s technology is aimed at improving the current-carrying capacity of wires and thus, the field strength of the magnet," noted Basu. "On the one hand, this makes the device more industrially viable and simple and on the other, it supports the development of a range of applications across industries."
 
The technology is expected to influence a wide spectrum of industries such as electrical power (generation, transmission, and distribution), healthcare, air travel and defense. It can also be applied in high-performance cryogen-free magnets for scientific nuclear magnetic resonance (NMR), accelerators and fusion reactors. In addition, it can benefit small hospitals in economically unstable nations in the form of low-cost, high-quality portable MRI.
 
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing a technology, which significantly impacts both the functionality and the customer value of new products and applications. The award lauds the relevance of the innovation to the industry.
 
For more information, visit: http://www.frost.com/prod/servlet/meawards.pag 

Related Content

High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Contrast-Free Cardiac MRI May Better Assess Need for Mitral Valve Surgery
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
A new study published in the Journal of the American College of Cardiology confirms non-invasive cardiac magnetic...
The FDA has cleared the Toshiba Vantage Galan 3.0T XGO Edition MRI from Canon Medical Systems.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac ...
Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI) | January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI) | December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Overlay Init